Extent of resection and survival in glioblastoma multiforme: Identification of and adjustment for bias - Commentary Article uri icon

Overview

MeSH Major

  • Brain Neoplasms
  • Glioblastoma
  • Neoplasm Recurrence, Local

abstract

  • Treatment bias was demonstrated regarding resection and second-line therapies. However, bias and imbalances were controllable in the cohorts available from the 5-aminolevulinic acid study so that the present data now provide Level 2b evidence (Oxford Centre for Evidence-based Medicine) that survival depends on complete resection of enhancing tumor in glioblastoma multiforme.

publication date

  • March 2008

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1227/01.neu.0000317304.31579.17

Additional Document Info

start page

  • 564

end page

  • 76; discussion 564-76

volume

  • 62

number

  • 3